BioLinker
PrivateLast Round
Angel
Jun 22, 2022
Total Funding Raised
$190,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
BioLinker is a biotechnology company that provides synthetic biology solutions, including cell-free protein expression kits and custom protein synthesis services for research and industrial applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioLinker Comparables
Compare BioLinker with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tierra Biosciences | 82% | |
| Synthelis Biotech | 81% | |
| LenioBio | 80% |
BioLinker Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Angel | Jun 22, 2022 | ||||
| Grant | Feb 4, 2021 |
BioLinker Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Financiadora de Estudos e Projetos | Grant |
| Cietec | Accelerator |
| FAPESP | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 44% MoM.
- Feb 1, 2026
Monthly visitors increased 77% MoM.
BioLinker Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BioLinker's valuation, stock price, and market status.
Is BioLinker a public or private company?
BioLinker is a private company.
What is the current stock price of BioLinker?
BioLinker is a private company with no public stock price. No recent secondary market data is available.
How much is BioLinker worth (valuation)?
Valuation information for BioLinker is not publicly available.
Can I buy BioLinker stock?
BioLinker shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BioLinker's last funding round?
BioLinker's most recent funding round was Angel on June 22, 2022.
Who are the main investors in BioLinker?
Key investors in BioLinker include Financiadora de Estudos e Projetos, Cietec, FAPESP.
Will BioLinker IPO soon?
No public IPO plans have been announced for BioLinker.
How can I track BioLinker secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioLinker's secondary market activity and sign up for updates.